Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.

Autor: Merat, Shahin, Sharifi, Amir-Houshang, Poustchi, Hossein, Hajiani, Eskandar, Gharavi, Abdolsamad, Karimi, Jalal, Mansour-Ghanaei, Fariborz, Fattahi, Mohammad-Reza, Ahmadi, Lida, Somi, Mohammad-Hossein, Kalantari, Hamid, Ghadir, Mohammad-Reza, Sheikhesmaeili, Farshad, Baniasadi, Nadieh, Sohrabi, Masoudreza, Moosavy, Seyedhamid, Ziaee, Masood, Zahedi, Mohammad-Javad, Mokhtare, Marjan, Sali, Shahnaz
Předmět:
Zdroj: Clinical Infectious Diseases; Jul2021, Vol. 73 Issue 1, p172-172, 1p
Abstrakt: A correction is presented to the article "SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial" which appeared in the previous issue.
Databáze: Complementary Index